Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Crisugabalin in Neuropathic Pain Related to NMOSD
NCT07699770Phase 4Not yet recruiting
- Sponsor
- Tangdu Hospital
- Start
- Jun 2026
- Primary completion
- Oct 2027
- Countries
- 1
01
Overview
A Phase 4 trial of crisugabalin besilate in neuropathic pain, sponsored by Tangdu Hospital. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
crisugabalin besilate
03
Conditions
neuropathic pain
Beyond the preview
Go deeper on NCT07699770.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07699770.